CA1301671C - Adn provenant du gene de la dystrophie musculaire type duchenne - Google Patents

Adn provenant du gene de la dystrophie musculaire type duchenne

Info

Publication number: CA1301671C
Authority: CA; Canada
Prior art keywords: dna; chromosome; translocation; gene; muscular dystrophy
Prior art date: 1986-12-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA000525918A

Other languages

English (en)

Inventor

Peter N. Ray

Margaret W. Thompson

Ronald G. Worton

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hsc Research Development Corp

Original Assignee

Hsc Research Development Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-19

Filing date

1986-12-19

Publication date

1992-05-26

1986-12-19 Application filed by Hsc Research Development Corp filed Critical Hsc Research Development Corp

1986-12-19 Priority to CA000525918A priority Critical patent/CA1301671C/fr

1992-05-26 Application granted granted Critical

1992-05-26 Publication of CA1301671C publication Critical patent/CA1301671C/fr

2009-05-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

108090000623 proteins and genes Proteins 0.000 title abstract description 42
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 title description 5
201000006938 muscular dystrophy Diseases 0.000 claims abstract description 32
210000001766 X chromosome Anatomy 0.000 claims abstract description 24
108020004414 DNA Proteins 0.000 claims description 65
239000012634 fragment Substances 0.000 claims description 49
230000005945 translocation Effects 0.000 claims description 44
239000003298 DNA probe Substances 0.000 claims description 7
108091028043 Nucleic acid sequence Proteins 0.000 claims description 7
108020003215 DNA Probes Proteins 0.000 claims description 5
210000002230 centromere Anatomy 0.000 claims description 5
238000013507 mapping Methods 0.000 claims description 5
210000003411 telomere Anatomy 0.000 claims description 5
108091035539 telomere Proteins 0.000 claims description 5
102000055501 telomere Human genes 0.000 claims description 5
239000002244 precipitate Substances 0.000 claims description 2
239000002773 nucleotide Substances 0.000 claims 1
125000003729 nucleotide group Chemical group 0.000 claims 1
239000000523 sample Substances 0.000 abstract description 39
201000010099 disease Diseases 0.000 abstract description 9
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
239000000969 carrier Substances 0.000 abstract description 6
230000005856 abnormality Effects 0.000 abstract description 2
238000011835 investigation Methods 0.000 abstract 2
210000000349 chromosome Anatomy 0.000 description 42
238000002105 Southern blotting Methods 0.000 description 19
210000004027 cell Anatomy 0.000 description 12
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 9
108020001027 Ribosomal DNA Proteins 0.000 description 8
210000004754 hybrid cell Anatomy 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
238000012217 deletion Methods 0.000 description 6
230000037430 deletion Effects 0.000 description 6
WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 6
239000002299 complementary DNA Substances 0.000 description 5
210000004090 human X chromosome Anatomy 0.000 description 5
210000003917 human chromosome Anatomy 0.000 description 5
238000000034 method Methods 0.000 description 5
108091008146 restriction endonucleases Proteins 0.000 description 5
238000005204 segregation Methods 0.000 description 5
239000000020 Nitrocellulose Substances 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
229920001220 nitrocellulos Polymers 0.000 description 4
108700022487 rRNA Genes Proteins 0.000 description 4
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 3
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 3
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000013459 approach Methods 0.000 description 3
238000002955 isolation Methods 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
229960003087 tioguanine Drugs 0.000 description 3
239000013598 vector Substances 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
238000000211 autoradiogram Methods 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
101150015424 dmd gene Proteins 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
230000035772 mutation Effects 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
238000012360 testing method Methods 0.000 description 2
LPMXVESGRSUGHW-UHFFFAOYSA-N Acolongiflorosid K Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CC(O)C3C2(CO)C(O)C1 LPMXVESGRSUGHW-UHFFFAOYSA-N 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
108091023242 Internal transcribed spacer Proteins 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
241000711408 Murine respirovirus Species 0.000 description 1
LPMXVESGRSUGHW-GHYGWZAOSA-N Ouabain Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1)[C@H]1C[C@@H](O)[C@@]2(CO)[C@@](O)(C1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)C[C@@H](O)[C@H]21 LPMXVESGRSUGHW-GHYGWZAOSA-N 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
241001468001 Salmonella virus SP6 Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
244000166550 Strophanthus gratus Species 0.000 description 1
208000017413 Taqi polymorphism Diseases 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
210000001840 diploid cell Anatomy 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000012252 genetic analysis Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
230000004807 localization Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
244000005700 microbiome Species 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000007479 molecular analysis Methods 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
230000008520 organization Effects 0.000 description 1
LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
229960003343 ouabain Drugs 0.000 description 1
238000007747 plating Methods 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
238000003793 prenatal diagnosis Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
238000012216 screening Methods 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229910052718 tin Inorganic materials 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
238000012800 visualization Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4707—Muscular dystrophy
- C07K14/4708—Duchenne dystrophy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Pathology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA000525918A 1986-12-19 1986-12-19 Adn provenant du gene de la dystrophie musculaire type duchenne Expired - Fee Related CA1301671C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000525918A CA1301671C (fr)	1986-12-19	1986-12-19	Adn provenant du gene de la dystrophie musculaire type duchenne

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000525918A CA1301671C (fr)	1986-12-19	1986-12-19	Adn provenant du gene de la dystrophie musculaire type duchenne

Publications (1)

Publication Number	Publication Date
CA1301671C true CA1301671C (fr)	1992-05-26

Family

ID=4134600

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000525918A Expired - Fee Related CA1301671C (fr)	1986-12-19	1986-12-19	Adn provenant du gene de la dystrophie musculaire type duchenne

Country Status (1)

Country	Link
CA (1)	CA1301671C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698686A (en) *	1994-10-20	1997-12-16	Arch Development Corporation	Yeast telomerase compositions

1986
- 1986-12-19 CA CA000525918A patent/CA1301671C/fr not_active Expired - Fee Related

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698686A (en) *	1994-10-20	1997-12-16	Arch Development Corporation	Yeast telomerase compositions
US5916752A (en) *	1994-10-20	1999-06-29	Arch Development Corporation	Telomerase screening methods
US6387619B1 (en)	1994-10-20	2002-05-14	Arch Development	Telomerase compositions and methods

Legal Events

Date	Code	Title	Description
2007-05-28	MKLA	Lapsed

Publication	Publication Date	Title
O'Connell et al.	1987	A primary genetic linkage map for human chromosome 12
Little et al.	1980	Model for antenatal diagnosis of β-thalassaemia and other monogenic disorders by molecular analysis of linked DNA polymorphisms
Ellis et al.	1996	Molecular genetics of Bloom's syndrome
Petit et al.	1988	Physical mapping of the human pseudo‐autosomal region; comparison with genetic linkage map.
Page et al.	1982	Single-copy sequence hybridizes to polymorphic and homologous loci on human X and Y chromosomes.
Brown et al.	1989	Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism
F. Davles et al.	1995	Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region
Kremer et al.	1991	Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p (CCG) n
Myers et al.	1990	Molecular cloning of alpha 5 (IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus
Smith et al.	1988	Regional assignment of the gene for human liver/bone/kidney alkaline phosphatase to chromosome 1p36. 1–p34
Segal et al.	1992	Correlation of genetic and physical structure in the region surrounding the I 2 Fusarium oxysporum resistance locus in tomato
Brueton et al.	1992	The mapping of a gene for craniosynostosis: evidence for linkage of the Saethre-Chotzen syndrome to distal chromosome 7p.
Baas et al.	1985	The human thyroglobulin gene: a polymorphic marker localized distal to C-MYC on chromosome 8 band q24
Pohl et al.	1988	Construction of a Not I linking library and isolation of new markers close to the Huntington's disease gene
Meo et al.	1980	Linkage analyses of murine immunoglobulin heavy chain and serum prealbumin genes establish their location on chromosome 12 proximal to the T (5; 12) 31H breakpoint in band 12F1.
Burk et al.	1985	Characterization and evolution of a single-copy sequence from the human Y chromosome
Hu et al.	1995	Genetic and physical mapping of the natural resistance-associated macrophage protein 1 (NRAMP1) in chicken
Patterson et al.	1987	Physical mapping studies on the human X chromosome in the region Xq27-Xqter
Montermini et al.	1995	The Friedreich ataxia critical region spans a 150-kb interval on chromosome 9q13
Mazarakis et al.	1991	Isolation and characterisation of a testis-expressed developmentally regulated gene from the distal inversion of the mouse t-complex
Stubbs et al.	1990	The HOX-5 and surfeit gene clusters are linked in the proximal portion of mouse chromosome 2
Glaser et al.	1989	Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively
Reeves et al.	1989	Mapping of PRM 1 to human chromosome 16 and tight linkage of Prm-1 and Prm-2 on mouse chromosome 16
Lathrop et al.	1989	Twenty-five loci form a continuous linkage map of markers for human chromosome 7
Wheeler et al.	1990	Microconversion between murine H-2 genes integrated into yeast